3.70
price down icon2.12%   -0.08
 
loading
전일 마감가:
$3.78
열려 있는:
$3.78
하루 거래량:
275.46K
Relative Volume:
0.68
시가총액:
$222.66M
수익:
-
순이익/손실:
$-197.68M
주가수익비율:
-0.984
EPS:
-3.76
순현금흐름:
$-158.88M
1주 성능:
+2.21%
1개월 성능:
+3.35%
6개월 성능:
-62.93%
1년 성능:
+52.26%
1일 변동 폭
Value
$3.65
$3.805
1주일 범위
Value
$3.51
$3.91
52주 변동 폭
Value
$1.92
$11.60

Kodiak Sciences Inc Stock (KOD) Company Profile

Name
명칭
Kodiak Sciences Inc
Name
전화
650-281-0850
Name
주소
1200 PAGE MILL RD, PALO ALTO, CA
Name
직원
113
Name
트위터
@kodiaksciences
Name
다음 수익 날짜
2024-11-12
Name
최신 SEC 제출 서류
Name
KOD's Discussions on Twitter

KOD을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
KOD
Kodiak Sciences Inc
3.70 222.66M 0 -197.68M -158.88M -3.76
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
441.30 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
521.00 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.83 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
560.14 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
241.20 28.51B 3.81B -644.79M -669.77M -6.24

Kodiak Sciences Inc Stock (KOD) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-12-09 업그레이드 Jefferies Hold → Buy
2024-09-05 개시 H.C. Wainwright Neutral
2023-12-11 재개 Goldman Sell
2023-11-17 업그레이드 CapitalOne Equal Weight → Overweight
2023-07-27 다운그레이드 UBS Buy → Neutral
2023-07-25 다운그레이드 Chardan Capital Markets Buy → Neutral
2023-07-25 다운그레이드 JP Morgan Neutral → Underweight
2023-07-24 다운그레이드 CapitalOne Overweight → Equal Weight
2023-07-24 다운그레이드 Jefferies Buy → Hold
2022-11-15 개시 CapitalOne Overweight
2022-08-02 다운그레이드 Citigroup Neutral → Sell
2022-02-24 다운그레이드 JP Morgan Overweight → Neutral
2022-02-11 개시 Goldman Buy
2022-02-02 업그레이드 JP Morgan Neutral → Overweight
2021-05-11 업그레이드 ROTH Capital Neutral → Buy
2021-03-12 개시 Evercore ISI Outperform
2021-03-01 다운그레이드 Barclays Equal Weight → Underweight
2021-02-17 다운그레이드 ROTH Capital Buy → Neutral
2021-01-25 다운그레이드 BMO Capital Markets Outperform → Market Perform
2020-12-17 개시 Berenberg Buy
2020-12-16 개시 UBS Buy
2020-12-11 개시 Citigroup Neutral
2020-11-30 다운그레이드 JP Morgan Overweight → Neutral
2020-11-16 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2020-11-13 다운그레이드 Goldman Buy → Neutral
2020-03-31 개시 BMO Capital Markets Outperform
2020-03-03 개시 Goldman Buy
2020-02-18 다운그레이드 Barclays Overweight → Equal Weight
2020-02-06 개시 SunTrust Buy
2020-01-08 개시 ROTH Capital Buy
2020-01-03 개시 Jefferies Buy
2019-12-24 개시 JP Morgan Overweight
2019-10-15 재확인 Chardan Capital Markets Buy
2019-02-20 개시 Chardan Capital Markets Buy
2018-10-29 개시 Barclays Overweight
2018-10-29 개시 BofA/Merrill Buy
2018-10-29 개시 Morgan Stanley Overweight
모두보기

Kodiak Sciences Inc 주식(KOD)의 최신 뉴스

pulisher
Jun 16, 2025

New one-year results for Kodiak's tarcocimab tedromer in the pivotal BEACON trial reinforce durability signal and demonstrate matched efficacy and comparable safety and tolerability in retinal vein occlusion - The Globe and Mail

Jun 16, 2025
pulisher
Jun 13, 2025

Why Is Kodiak Sciences (KOD) Up 10.5% Since Last Earnings Report? - Yahoo Finance

Jun 13, 2025
pulisher
Jun 10, 2025

Millennium Management LLC Cuts Holdings in TriSalus Life Sciences, Inc. (NASDAQ:TLSI) - Defense World

Jun 10, 2025
pulisher
Jun 07, 2025

Kodiak Sciences Q2 EPS Forecast Decreased by Zacks Research - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

Kodiak Sciences Inc. (NASDAQ:KOD) Position Increased by Public Employees Retirement System of Ohio - Defense World

Jun 06, 2025
pulisher
Jun 04, 2025

Retinal Vein Occlusion Pipeline Appears Robust With 15+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - The Globe and Mail

Jun 04, 2025
pulisher
Jun 03, 2025

Kodiak Sciences Holds 2025 Annual Stockholders Meeting - TipRanks

Jun 03, 2025
pulisher
May 29, 2025

Kodiak Sciences to Present at 2025 Jefferies Global Healthcare C - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Kodiak Sciences Reveals Latest Retinal Disease Breakthroughs at Major Healthcare Conference - Stock Titan

May 29, 2025
pulisher
May 29, 2025

Kodiak Sciences to Present at 2025 Jefferies Global Healthcare Conference - Yahoo Finance

May 29, 2025
pulisher
May 28, 2025

Kodiak Sciences’ SWOT analysis: eye disease biotech stock at crossroads - Investing.com Australia

May 28, 2025
pulisher
May 27, 2025

Kodiak Sciences’ SWOT analysis: eye disease biotech stock at crossroads By Investing.com - Investing.com India

May 27, 2025
pulisher
May 25, 2025

Kodiak Q1 Loss Wider Than Expected, Pipeline Development in Focus - The Globe and Mail

May 25, 2025
pulisher
May 19, 2025

Kodal Minerals Nears Export Permit For Mali Lithium Project - Finimize

May 19, 2025
pulisher
May 15, 2025

Kodiak Sciences Inc Reports Q1 2025 Earnings: EPS of -$1.09 Misses Estimates, No Revenue Reported - GuruFocus

May 15, 2025
pulisher
May 14, 2025

KOD Plans to Unveil Key Developments as Phase 3 Trials Progress - GuruFocus

May 14, 2025
pulisher
May 14, 2025

KOD Plans to Unveil Key Developments as Phase 3 Trials Progress | KOD Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Kodiak Sciences Announces Recent Business Highlights and First Q - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Kodiak Sciences Reports Deeper Q1 Loss: What 3 Key Phase 3 Trials Mean for Future Growth - Stock Titan

May 14, 2025
pulisher
May 14, 2025

Kodiak Sciences (KOD) Projected to Post Earnings on Wednesday - Defense World

May 14, 2025
pulisher
May 13, 2025

Kodiak Sciences Inc. (NASDAQ:KOD) Shares Acquired by Dimensional Fund Advisors LP - Defense World

May 13, 2025
pulisher
May 09, 2025

MetLife Investment Management LLC Makes New $209,000 Investment in Kodiak Sciences Inc. (NASDAQ:KOD) - The AM Reporter

May 09, 2025
pulisher
May 09, 2025

MetLife Investment Management LLC Invests $209,000 in Kodiak Sciences Inc. (NASDAQ:KOD) - Defense World

May 09, 2025
pulisher
May 09, 2025

Wells Fargo & Company MN Sells 2,710 Shares of Kodiak Sciences Inc. (NASDAQ:KOD) - Defense World

May 09, 2025
pulisher
May 07, 2025

Ratio Review: Analyzing Kodiak Sciences Inc (KOD)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX

May 07, 2025
pulisher
May 07, 2025

Retinal vein occlusion Market: Epidemiology, Therapies, - openPR.com

May 07, 2025
pulisher
May 06, 2025

BlackRock, Inc. Reduces Stake in Kodiak Sciences Inc. - GuruFocus

May 06, 2025
pulisher
May 02, 2025

Kodiak Sciences Data at ARVO 2025 Highlight Power and Versatilit - GuruFocus

May 02, 2025
pulisher
May 02, 2025

CND Life Sciences Closes $13.5M Series A Equity Round to Continue Growth and Innovation in Neurodiagnostics - The Malaysian Reserve

May 02, 2025
pulisher
May 01, 2025

Breakthrough Eye Disease Platform: Kodiak Sciences Reveals 7 Major Advances at ARVO 2025 - Stock Titan

May 01, 2025
pulisher
May 01, 2025

Kodiak Sciences Data at ARVO 2025 Highlight Power and Versatility of ABC Platform in Addressing Complex Multifactorial Ocular Diseases - Yahoo Finance

May 01, 2025
pulisher
Apr 30, 2025

Wet Age-Related Macular Degeneration Treatment Market 2034: EMA, PDMA, FDA Approvals, Clinical Trials, Medication, Therapies, NICE Approvals, Prevalence, and Companies by DelveInsight - Barchart.com

Apr 30, 2025
pulisher
Apr 27, 2025

JPMorgan Chase & Co. Increases Holdings in Kodiak Sciences Inc. (NASDAQ:KOD) - Defense World

Apr 27, 2025
pulisher
Apr 24, 2025

Kodiak Sciences Inc [KOD] Shares Rise 9.62 % on Wednesday - knoxdaily.com

Apr 24, 2025
pulisher
Apr 24, 2025

A year in review: Kodiak Sciences Inc (KOD)’s performance in the last year - uspostnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

Insider’s View: Deciphering Kodiak Sciences Inc (KOD)’s Financial Health Through Ratios - DWinneX

Apr 24, 2025
pulisher
Apr 18, 2025

April 2025's Promising Penny Stocks - Yahoo

Apr 18, 2025
pulisher
Apr 17, 2025

AMKR Shares Experience Decline in Value - knoxdaily.com

Apr 17, 2025
pulisher
Apr 17, 2025

Age Related Vision Dysfunction Market to Reach New Heights - openPR.com

Apr 17, 2025
pulisher
Apr 17, 2025

Age Related Vision Dysfunction Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Kodiak Sciences Inc., Outlook Therapeutics, Eye point Pharmaceuticals - The Globe and Mail

Apr 17, 2025
pulisher
Apr 15, 2025

Why Coffee Prices Remain Volatile - The Globe and Mail

Apr 15, 2025
pulisher
Apr 12, 2025

Prudential Financial Inc. Sells 65,400 Shares of Kodiak Sciences Inc. (NASDAQ:KOD) - Defense World

Apr 12, 2025
pulisher
Apr 11, 2025

Wet Age-Related Macular Degeneration Therapeutics Market Size - openPR.com

Apr 11, 2025
pulisher
Apr 09, 2025

Sei Investments Co. Sells 69,599 Shares of Kodiak Sciences Inc. (NASDAQ:KOD) - Defense World

Apr 09, 2025
pulisher
Apr 04, 2025

Kodiak Sciences stock hits 52-week low at $2.15 - Investing.com India

Apr 04, 2025
pulisher
Apr 04, 2025

HC Wainwright Comments on Kodiak Sciences Q2 Earnings - Defense World

Apr 04, 2025
pulisher
Apr 03, 2025

HC Wainwright Forecasts Kodiak Sciences Q1 Earnings - Defense World

Apr 03, 2025
pulisher
Apr 01, 2025

Down -28.08% in 4 Weeks, Here's Why You Should You Buy the Dip in Kodiak Sciences (KOD) - Yahoo Finance

Apr 01, 2025

Kodiak Sciences Inc (KOD) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$20.50
price down icon 1.11%
$35.87
price up icon 1.70%
$20.60
price down icon 3.38%
$99.49
price down icon 2.21%
$106.72
price up icon 0.55%
biotechnology ONC
$241.20
price down icon 5.22%
자본화:     |  볼륨(24시간):